chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I began having pain and tightness in my chest 3-4 hours after receiving my 3rd booster vaccine shot for Covid-19. My heart rate also increased and was palpitating. If I were to rate the pain on a scale of 1-10, I would rate it a 3. The pain increased when I lay down and when I breathed in deeply. After looking online for possible causes, I read that it might be heart inflammation.cont
MEMBER HAD SYNCOPE EPISODE AFTER RECEIVING 4 VACCINES.  MEMBER HAD POSITIVE LOC FOR 20 TO 30 SECONDS. MEMBER WAS THEN MONITORED AND GIVEN ORAL HYDRATION.
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE HYPOXEMIC RESPIRATORY FAILURE ALLERGIC REACTION, INIT
Hardness at injection site - red arm (Right). Chills, dry lips, very red, mouth coating (torn lips) and taste buds affected. Burning skin, swollen arm (entire).
Reportedly, within one week of the vaccination, the patient experienced head throbbing and pressure. The patient stated that her physician told her that her symptoms were not related to the vaccination. In late June 2000, the patient reportedly received her second injection. The patient stated that the head throbbing and pressure were ongoing at the time the second injection was administered. One week after the second injection, her symptoms increased in severity and the patient began to experience ringing in her ears. The patient also reported that she began experiencing exhaustion, extreme anxiety, depression, hypertension and elevated cholesterol. The patient stated that her blood pressure increased from 120/70 to 190/100. The patient's primary physician prescribed an antihypertensive medication which she took for 1 to 2 months. Reportedly, after this treatment, the patient's blood pressure returned to normal and the medication was discontinued. The patient's cholesterol increased from 180 to 268. The patient was treated with Lipitor for approximately 2 months, after which her cholesterol returned to 180. The patient was also treated with Xanax, which reportedly had no effect. The patient was seen by an ear specialist who made a diagnosis of tinnitus. This specialist declined to treat the patient. The patient was seen by a nutritionist, who reportedly treated the patient with herbs. There was no effect on her symptoms. The patient was seen by a neurologist who prescribed Paxil. The patient was seen by a gynecologist who prescribed Loestrin, Xanax and an unspecified medication for bloating. These medications reportedly had no effect. The patient was seen by a psychiatrist, who increased the Paxil dosage. This medication change had no effect. The patient was then seen by a homeopath whose conclusion was "bacteria in the system and either Lyme disease or a reaction to Lymerix". The patient was treated by stopping all medications and starting vitamin supplements to "detox the system". The patient stated that she felt somewhat better within 2 weeks. The patient was then seen by an infection control physician who found she had symptoms of Lyme, but that it could not be proven. The patient then returned to her primary physician, who reportedly informed her that her symptoms were without a doubt a reaction to the vaccine. As of 10/04/2001, the patient stated that the head throbbing and pressure, tinnitus, exhaustion, anxiety, and depression persisted, but have been milder since treatment by the homeopathic physician. The elevated cholesterol and hypertension had resolved.
MS Exacerbation, severe cereal edema, requiring steroid therapy and hospitalization, followed by weeks of physical therapy.
Patient experienced lightheadness and was dizzy and unbalanced. Blood pressure fell to 93/46 P=69. Complexion was pale. Had patient site. Gave cold water and Snickers bar. She felt better after 10 minutes. BP returned to 98/74 P=81.
TESTED + 2-18-23 AS OUTPAT, TO ER 3-2-23 WITH WORSENING DYSPNEA FOR 2-3 WEEKS.   fLUID OVERLOAD GIVEN BUMEX.   HAD INTUBATION AND WAS LATER EXTUBATED.   ACUTE ON CHRONIC RESP FAILURE COVID RENAL FAILURE CHRONIC AFIB PNEUMONIA WERE AMONG DC DIAGNOSIS.    PATIENT WAS SENT HOME WITH HOSPICE , DECEASED ON 3-12-23
PATIENT REPORTED JAW PAIN, SEVERE EXHAUSTION, TOTAL BODY MUSCLE PAIN AND LOCAL SITE PAIN, ONGOING FOR OVER 1 WEEK, REFERRED PATIENT TO DOCTOR TO FOLLOW-UP.
Sense of smell and taste altered horribly.  Constantly smelling things that are not there or complete change in the way things taste and smell.  Constantly smeeling things that are rotting or dirty feet or chemical smell.
About a week or two after second shot. developed strange nerve pain in right foot large toe. Was mainly noticeable when pointing foot down and especially if shaking leg. Tingling pain would work way from toe, up foot. This lasted for a little over a month and then went away suddenly in July.  Related to vaccine? No idea, but was strange and had never happened before. Didn't make connection the two could be related until recerntly.
throw-up; Feeling cold; Did not eat for two days; arm redness and swollen at the injection site; arm redness and swollen at the injection site; Chills; Fever; Nausea; Tired; Stomach ache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (arm redness and swollen at the injection site), VACCINATION SITE SWELLING (arm redness and swollen at the injection site), CHILLS (Chills), PYREXIA (Fever) and NAUSEA (Nausea) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (arm redness and swollen at the injection site), VACCINATION SITE SWELLING (arm redness and swollen at the injection site), CHILLS (Chills), PYREXIA (Fever), NAUSEA (Nausea), FATIGUE (Tired) and ABDOMINAL PAIN UPPER (Stomach ache). On an unknown date, the patient experienced VOMITING (throw-up), FEELING COLD (Feeling cold) and DECREASED APPETITE (Did not eat for two days). In January 2021, VACCINATION SITE ERYTHEMA (arm redness and swollen at the injection site), VACCINATION SITE SWELLING (arm redness and swollen at the injection site), NAUSEA (Nausea), FATIGUE (Tired) and ABDOMINAL PAIN UPPER (Stomach ache) was resolving. On 24-Jan-2021, CHILLS (Chills) and PYREXIA (Fever) had resolved. At the time of the report, VOMITING (throw-up), FEELING COLD (Feeling cold) and DECREASED APPETITE (Did not eat for two days) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In November 2020, COVID-19: positive tested positive.. On 22-Jan-2021, Body temperature: 101 °F High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
LIPS TINGLING, HEADACHE, TIGHTNESS IN THROAT, BURNING RIGHT ARM, BURNING SENSATION IN TOES
Approx 2AM 15AUG91 pt had emesis & t102, APAP given, pt continued w/fever; Mom phoned clinic & advised continue giving APAP & sponge down; Also told to take to MD which she did; MD felt viral illness & that high fever wasn't due to immun;
Patient discovered to be pregnant on this date, 9 February, 2006.  She received the Anthrax vaccine (2nd shot in series) the 8th February, 2006.
Recvd vaxs 24Oct.That noc had fever, irritability, vomiting & diarrhea-this cont until 4am 28Oct.That day was "OK" until afternoon began vomit/fever/irritability again.29Oct 9am took bottle -vomited,warm took to MD-to hosp-admitted.Tx /w IV
Patient was given their flu vaccine. The medical assistant left the exam room to collect his lab orders. The medical assistant and the patient walked to the lab down the hall. The medical assistant attempted to draw his blood and missed. She began to dress the area and the patient stated, "I'm starting to feel fuzzy." The medical assistant stated his eyes rolled back in his head and he fell forward and she had caught him before he fell. Nurse was walking in the hall and saw and helped assist right as the patient started to have a seizure. 911 was notified and responded. Patient regained consciousness and was taken to the local ED.
36 weeks pregnant and had to get the Tdap shot, the next day after receiving the shot my arm was extremely sore and in a lot of pain/discomfort and could barely get any sleep. Started getting fevers and chills Thursday night into Friday and my blood pressure was slightly raised. Had to go check into labor and delivery so they could monitor the baby's heart rate (baby's heart rate was a little high possibly due to my fever). Still experiencing pain discomfort on arm where I received the shot. My fever went down, but was starting to have contractions with no dilation. I was finally discharged from the hospital Friday night. Around 2:30 am Saturday I had a slight fever, took TYLENOL and hadn't had a fever since. But on Sunday I had a few dizzy spells and felt nauseous for about 2 hours. It is Monday morning and I am still have extreme soreness on my arm to the point I can't even sleep. (4 days after receiving the Tdap shot).
mucous membrane of her mouth peeling; mouth sore; Based on information received on 02-Sep-2020, the report previously considered as non-valid became valid as adverse event specified in the case.  Initial information was received on 01-Sep-2020 regarding an unsolicited valid non-serious case from the patient   This case involves a female patient (age was not reported) who experienced sore mouth (oral pain) and mucous membrane of her mouth started peeling (oral mucosal exfoliation),  while she received vaccine INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV] and while treated with CELECOXIB [CELEBREX] and LEVOFLOXACIN [LEVAQUIN].  The patient was vaccinated with 2 doses of Influenza Vaccine containing H1N1 antigen in the past since 1975 for prophylactic vaccination and had similar reactions (oral mucosal exfoliation and oral pain) when she takes medication that contains sulfa products.  The patient's family history and concomitant medications were not provided.  On an unknown date in 2018, the patient received a 0.5 ml dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE (batch number and other dosing details were not reported) for prophylactic vaccination. On an unknown date, the patient started taking CELECOXIB [CELEBREX] and LEVOFLOXACIN [LEVAQUIN] (batch number and other dosing details were not reported) for unknown indication.  On an unknown date, the mucous membrane of her mouth started peeling (oral mucosal exfoliation) and experienced sore mouth (oral pain), (unknown latency), following the administration of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE, following the first dose intake and last dose intake of CELECOXIB and LEVOFLOXACIN.  These reactions were very strong.  Details of laboratory data were not reported.  The action taken for CELECOXIB [CELEBREX] and LEVOFLOXACIN [LEVAQUIN] was not reported.  The patient did not receive corrective treatment and just avoided eating foods that would aggravate the condition such as spicy foods.  On an unknown date, the patient had recovered from the events after several days.  There will be no information available on the batch number for this case.  Follow up information was received on 02-Sep-2020 regarding an unsolicited valid non-serious case from the patient via phone  Case upgraded from non-valid to valid, new suspect drugs and events added.
COVID-19 Treatment; COVID-19 Treatment; Vaccine brand other: Pfizer / BioNTech, Vaccine administration date: 26Apr2022/Vaccine brand other: Moderna, Vaccine administration date: 19Oct2022,; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 67-year-old female patient received BNT162b2 (BNT162B2), on 26Apr2022 as dose 4 (booster), single (Lot number: FK9895) at the age of 67 years, in left arm for covid-19 immunization; elasomeran (MODERNA COVID-19 VACCINE), on 09Feb2021 as dose 1, single (Lot number: 012M20A), in left arm, on 09Mar2021 as dose 2, single (Lot number: 002A21A), in left arm, on 19Nov2021 as dose 3 (booster), single (Lot number: 039F21A), in left arm and on 19Oct2022 as dose 5 (booster), single (Lot number: 061F22A), in left arm for covid-19 immunization. The patient's relevant medical history included: "Hashimotos" (unspecified if ongoing). The patient took concomitant medications. Past drug history included: Nitrofurantoin, reaction(s): "Known Allergies: Nitrofurantoin". The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 26Apr2022, outcome "not recovered", described as "Vaccine brand other: Pfizer / BioNTech, Vaccine administration date: 26Apr2022/Vaccine brand other: Moderna, Vaccine administration date: 19Oct2022,"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID-19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: COVID 19 Treatment; Positive, notes: Positive Covid rapid antigen test on day 8 after finishing paxlovid 8 days earlier. Therapeutic measures were taken as a result of drug ineffective, covid-19 with Paxlovid from 07Jan2023 to 12Jan2023.
12 days after receiving the vaccine, a 2 inch square, red rash developed approximately 2 inches below the injection site.
Received the two shots husband has just come down with it/ Suspected vaccination failure; Husband has just come down with it; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix and the 1st dose of Shingrix. On an unknown date, several years after receiving Shingrix and unknown after receiving Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix and Shingrix.     Additional Information: GSK Receipt Date: 28-JUN-2022 Reporter's Comments: This case was reported by patient's wife via interactive digital media. The patient received both the shots of Shingrix a couple of years ago from reporting, thought he could not get shingles after it. However, the patient had just come down with Shingles. The reporter also had received both the shots and asked if that meant that they should get more shots. Additional Supportive Information: This case was considered as suspected vaccination failure as detail regarding the laboratory test confirming shingles was unknown at the time of reporting. The follow-up would not possible as no contact details were available.
no appetite; flu like symptoms; feels like has been hit by a truck; Fever; terrific headache; Injection arm pain; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (no appetite), INFLUENZA LIKE ILLNESS (flu like symptoms), FEELING ABNORMAL (feels like has been hit by a truck), PYREXIA (Fever) and HEADACHE (terrific headache) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced VACCINATION SITE PAIN (Injection arm pain). On 05-Mar-2021, the patient experienced DECREASED APPETITE (no appetite), INFLUENZA LIKE ILLNESS (flu like symptoms), FEELING ABNORMAL (feels like has been hit by a truck), PYREXIA (Fever) and HEADACHE (terrific headache). At the time of the report, DECREASED APPETITE (no appetite), INFLUENZA LIKE ILLNESS (flu like symptoms), FEELING ABNORMAL (feels like has been hit by a truck), PYREXIA (Fever), HEADACHE (terrific headache) and VACCINATION SITE PAIN (Injection arm pain) outcome was unknown.            Reporter did not allow further contact
9 days after the shot a bright red circle appeared around the injection site. Did not hurt or itch. Took about 5 days to disappear.
FLU LIKE SYMPTOMS, FAVORING, VOMITING, SHORTNESS OF BREATH, WORST BODY PAIN, NAUSEA, SHIVERS; SHINGLES, RED DOTS, HURT ITCHY LEGS; This spontaneous report received from a patient concerned a 30 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient had no past episode. The patient tried steroids for couple of weeks but did not work and followed up with doctor. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808609, expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. Concomitant medications included sertraline.  On APR-2021, the patient experienced shingles, red dots, hurt itchy legs. On 07-APR-2021, the patient experienced flu like symptoms, favoring, vomiting, shortness of breath, worst body pain, nausea, shivers. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from flu like symptoms, favoring, vomiting, shortness of breath, worst body pain, nausea, shivers, and shingles, red dots, hurt itchy legs. This report was non-serious.
Redness and swelling at injection site, patient thinks it may be due to undisclosed scar tissue in area.
redness approx 1" around inject site w/tiny blisters on same area <24 hrs; no systemic sx;
A blood clot in my left lung; Chronic asthma; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PULMONARY THROMBOSIS (medically significant), outcome "unknown", described as "A blood clot in my left lung"; ASTHMA (non-serious), outcome "unknown", described as "Chronic asthma".  Clinical information: After getting COVID vaccine, patient developed chronic asthma and a blood clot in left lung now patient on blood thinner, Eliquis, but patient couldn't afford it because patient a senior and insurance does not cover meds since patient have to take the blood thinner due to vaccine.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Acute otitis media, nonsuppurative; after 7 days of symptoms, treated with cirpoflaxin ear drops, mostly improved after 7 days of treatment
Rib pain; Itchy every where; Pin needle pain near breast; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL CHEST PAIN (Rib pain), PRURITUS (Itchy every where) and PAIN (Pin needle pain near breast) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCULOSKELETAL CHEST PAIN (Rib pain), PRURITUS (Itchy every where) and PAIN (Pin needle pain near breast). At the time of the report, MUSCULOSKELETAL CHEST PAIN (Rib pain), PRURITUS (Itchy every where) and PAIN (Pin needle pain near breast) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant and treatment medications were reported.
Daughter got GARDASIL vaccination on 01/07/2010, the second vaccination of the three required, on 01/09/2010, she developed a severe headache and has it to this day. She has not been able to attend school for the past two months and was hospitalized. She has had numerous tests, including two CT scans, a lumbar test, and  a MRI; these tests were all negative, yet the headache persists. She has been given strong migraine medicines, one of these took the pain away for two days, but the headache returned after she was released from the hospital. She is still in severe pain and seeing a doctor at least once a week.
Patient given 2 doses of the Pfizer pediatric COVID-19 vaccine at 16:00 today.
eyes are sensitive to light; constant headache; This spontaneous case was reported by a consumer and describes the occurrence of PHOTOPHOBIA (eyes are sensitive to light) and HEADACHE (constant headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PHOTOPHOBIA (eyes are sensitive to light) and HEADACHE (constant headache). At the time of the report, PHOTOPHOBIA (eyes are sensitive to light) and HEADACHE (constant headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no treatment reported   Reporter did not allow further contact
Pt experienced a fainting episode in the early morning of 4/3/22. She then checked her blood pressure and saw that it was 90/60. She has been feeling faint since but not bad enough to seek medical care.
Patient received vaccine at 951 then presented back at clinic at 1100am. Presented with flushing, followed by clammy feeling and slight rash, tachycardia about 1 hour post vaccination. Patient was given Benadryl 50mg, Solu- Medrol 125mg and Pepcid 20mg on 12/30/20 @ 1120
Allergic to the flu shot; This spontaneous case was received on 02-Mar-2021 from other non-health professional (consumer) via company (reference number: NUS2021US032466) and concerned a female patient of an unreported age.  The patient's medical history and concomitant medications were not reported.   On an unspecified date, the patient was vaccinated with influenza virus vaccine polyvalent (brand not specified; indication, dose, route of administration and anatomical location: not reported). The batch number was not reported.  On an unspecified date, unknown amount of time after receiving influenza virus vaccine polyvalent, the patient was allergic to the flu shot and her mother was the same way (refer to the case 202101644).  The outcome of the event was not reported.  The reporter assessed the event of 'allergy to vaccine' as related to influenza virus vaccine polyvalent.  The case was assessed as non-serious.  This case is linked with case 202101644 (due to the same reporter).  Company comment: The event of 'allergy to vaccine' is considered as unassessable to influenza virus vaccine polyvalent.; Reporter's Comments: Patient said that she's even allergic to the flu shot.; Sender's Comments: The event of 'allergy to vaccine' is considered as unassessable to influenza virus vaccine polyvalent.
within a day or few days after flu vaccine administration patient gradually developed rash to chest, abdomen, back, which reached peak 7 days after vaccination and has persisted to this day Jan 9, 2020: diagnosed as pityriasis rosea